FDA Inspection 1321580 — Trifluent Pharma LLC

Trifluent Pharma LLC — FEI 3027672712

The FDA completed an inspection of Trifluent Pharma LLC on Jun 11, 2026 in San Antonio, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 11, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Antonio, TX (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
155021 CFR 211.125(f)Procedures Written and Followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.